A billion something company with lots and lots of debt, share price in decline, a US company, an offer that is not clear on how people will receive funds, dubious history, high risk etc etc.... ad nauseam.
Whereas DLS does what it says on the box.
The current SP and SP action is by no means a fair reflection on DLS's future or indeed value as the price is being strictly controlled by external forces namely algo trading. You can witness this every day in the Buy/Sell depth ratio. Currently with the market closed it is 1:1. As soon as the market opens the Buy plunge protection team moves in and reduces the B/S ratio (double entendre intended) reduces to 1:2 or at least 2:3 thereby keeping the pressure on the sell side. I is quite clear to me that we are all waiting for news that is due soon and we are all hoping that there is an upside surprise. In the meantime what happens with the SP is irrelevant and is especially irrelevant to base any comments on.
DLS has something tangible to offer AQO shareholders and it was quite clear that money is not the only consideration to take into account. This was highlighted by the board. In any event the MH offer gap has closed significantly which highlights the higher risk in accepting the MH offer.
All the best to all holders.
Cheers
BW
- Forums
- ASX - By Stock
- AQO
- Ann: DLS: Notice of Variation - Extension of Offer Period
-
- There are more pages in this discussion • 51 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AQO (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online